Fluconazole in hypercalciuric patients with increased 1,25(OH)2D levels: the prospective, randomized, placebo-controlled, double-blind FLUCOLITH trial

Peer Review reports

Original Submission
21 Oct 2021	Submitted	Original manuscript
11 Jan 2022	Reviewed	Reviewer Report - Kirsty Loudon
12 Apr 2022	Author responded	Author comments - Aurélia Bertholet-Thomas
Resubmission - Version 2
12 Apr 2022	Submitted	Manuscript version 2
Publishing
13 Apr 2022	Editorially accepted
16 Jun 2022	Article published	10.1186/s13063-022-06302-z

Back to article page